Medtronic (MDT) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)

Medtronic (MDT) Net Income towards Common Stockholders Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -6.51%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 7.96%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.19%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 29.56%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 0.80%

Historic Data

Download Data
DateValue
Jan 23, 2026 -2.19%
Oct 24, 2025 46.90%
Jul 25, 2025 3.95%
Apr 25, 2025 -10.71%
Jan 24, 2025 -4.22%
Oct 25, 2024 -1.00%
Jul 26, 2024 21.04%
Apr 26, 2024 -17.97%
Jan 26, 2024 6.43%
Oct 27, 2023 38.62%
Jul 28, 2023 32.27%
Apr 28, 2023 33.12%
Jan 27, 2023 -11.52%
Oct 28, 2022 -29.23%
Jul 29, 2022 7.85%
Apr 29, 2022 12.03%
Jan 28, 2022 8.56%
Oct 29, 2021 9.14%
Jul 30, 2021 -15.28%
Apr 30, 2021 -4.37%